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Abstract Purpose: Seizures are
common in comatose children, but may
be clinically subtle or only manifest on
continuous electroencephalographic
monitoring (cEEG); any association
with outcome remains uncertain.
Methods: cEEG (one to three chan-
nels) was performed for a median 42 h
(range 2–630 h) in 204 unventilated
and ventilated children aged
B15 years (18 neonates, 61 infants) in
coma with different aetiologies. Out-
come at 1 month was independently
determined and dichotomized for sur-
vivors into favourable (normal or
moderate neurological handicap) and
unfavourable (severe handicap or
vegetative state). Results: Of the 204
patients, 110 had clinical seizures (CS)
before cEEG commenced. During
cEEG, 74 patients (36 %, 95 % confi-
dence interval, 95 % CI, 32–41 %) had
electroencephalographic seizures
(ES), the majority without clinical
accompaniment (non-convulsive sei-
zures, NCS). CS occurred before NCS
in 69 of the 204 patients; 5 ventilated
with NCS had no CS observed. Death
(93/204; 46 %) was independently
predicted by admission Paediatric
Index of Mortality (PIM; adjusted odds
ratio, aOR, 1.027, 95 % CI
1.012–1.042; p \ 0.0005), Adelaide
coma score (aOR 0.813, 95 % CI
0.700–0.943; p = 0.006), and EEG
grade on admission (excess slow with
[3 % fast, aOR 5.43, 95 % CI
1.90–15.6; excess slow with\3 %
fast, aOR 8.71, 95 % CI 2.58–29.4;
low amplitude, 10th centile\9 lV,
aOR 3.78, 95 % CI 1.23–11.7; and
burst suppression, aOR 10.68, 95 % CI
2.31–49.4) compared with normal
cEEG, as well as absence of CS at any
time (aOR 2.38, 95 % CI 1.18–4.81).
Unfavourable outcome (29/111 survi-
vors; 26 %) was independently
predicted by the presence of ES (aOR
15.4, 95 % CI 4.7–49.7) and PIM
(aOR 1.036, 95 % CI 1.013–1.059).
Conclusion: Seizures are common in
comatose children, and are associated
with an unfavourable outcome in sur-
vivors. cEEG allows the detection of
subtle CS and NCS and is a prognostic
tool.
Keywords Seizures  Status
epilepticus  Coma  Child  Outcome
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Introduction
Seizures may be difficult to detect in unconscious chil-
dren, particularly if the episode is partial or subtle or
when neuromuscular blocking (NMB) agents are used
during mechanical ventilation [1]. Electroencephalogra-
phy (EEG) may be helpful in this situation, but there are a
range of possibilities when observing electroencephalo-
graphic seizure (ES) activity. For example, in the child
who is able to move, if there is no convulsive activity,
then the state could be defined as non-motor, non-con-
vulsive seizures (NCS). Alternatively, there may be subtle
clinical features of epileptic nystagmus or facial myoc-
lonus [2–4]. Monitoring with continuous EEG (cEEG) in
neonates and older children is sensitive for detection of
ES, with few false-positives [5–7]. ES may be frequent,
with a prolonged time-course [8–16], but their signifi-
cance is unknown, so it not clear whether cEEG is
advisable or anticonvulsant treatment should be given for
subtle seizures, NCS and/or ES in comatose patients or
those receiving NMB agents. In order to answer this
question, we need to know whether there is a relationship
between these events and eventual outcome, independent
of underlying aetiology.
The purpose of this study was to examine the preva-
lence of ES in comatose children and to determine any
association of subtle seizures or ES with mortality and
morbidity.
Methods
Ethical approval
The research ethics committees of Guys Hospital Medical
School and the Kenyan Medical Research Institute gave
ethical approval for the work undertaken in their respective
institutions. At the time of this observational study, indi-
vidual written informed consent was not required to report
clinically indicated monitoring or follow-up, but the
investigators discussed the research with parents or
guardians and obtained verbal consent to monitor EEG
activity and to follow-up the patients as part of clinical care.
Study populations
Two prospectively recruited consecutive cohorts of
unconscious children without previous acute neurological
injury underwent cEEG monitoring. In the first (Guy’s
Hospital, London) all of the children were mechanically
ventilated and received pancuronium for NMB. In the
second (Kenya Medical Research Institute, Kilifi, Kenya)
none of the children underwent mechanical ventilation
since facilities were not available, and so they could be
assessed clinically. Any child older than 1 month with an
acute encephalopathy and a summated Adelaide coma
score (ACS) [17] less than normal for age was eligible,
and as there was sufficient monitoring equipment avail-
able, all had cEEG monitoring until they were able to
localize a painful stimulus ([9 months) or flex to pain
(\9 months) or death.
Clinical observations
Diagnosis followed standard definitions (see ‘‘Aetiology
of coma’’). In unventilated patients, level of conscious-
ness was assessed on admission and then 6-hourly using
the ACS until the child was drinking. In ventilated
patients, ACS was obtained on admission. Thereafter,
clinical examination or detection of clinical seizures (CS)
was usually precluded by the use of medication for
sedation and NMB. In all patients, clinical signs sugges-
tive of seizures, such as jerking, or increases in blood
pressure or heart rate, were noted. In patients without
mechanical ventilation, if ES were noted on the cEEG, the
bedside attendant undertook a careful clinical examina-
tion. Evidence of subtle CS (e.g. changes in pupil
response, blood pressure, or heart rate, or clonic move-
ments of the digits, face or eyes) was recorded.
Electroencephalography
Two EEG devices and montages were used in these
studies. In 52 patients managed at Guy’s hospital, the
output from a three-channel Oxford Medilog EEG
machine [14, 15] with disc electrodes placed at F4–P4 and
F3–P3 and C3–C4 on the International 10–20 system
(reference electrodes just behind the hairline) was dis-
played in real time at the bedside (Siemens monitor,
Erlangen, Germany) and the raw EEG was replayed off-
line through a commercial system (Oxford Systems,
Oxford, UK). This equipment did not include amplitude
and frequency integration, and staff found it difficult to
recognize seizures (Fig. 1) in real time. Therefore, in the
remaining 152 patients, including all 46 Kenyans, a one-
or two-channel cerebral function analysing monitor
(CFAM) [7, 8] was used, calibrated using a conventional
multichannel EEG. The disc electrodes were placed at P3–
P4 (reference electrode just behind the hairline) for single
channel monitoring (n = 118), or P3–P4 and F4–P4 for
bilateral monitoring (n = 34) with data displayed on a
paper trace with raw EEG displayed automatically at least
every 10 min. A button could be pressed by attending staff
to record raw EEG during increases in amplitude repre-
senting possible seizures (Fig. 2). Electrode impedance
was maintained below 2 kOhm and mains artefact as low
as possible [11, 14].
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Clinical management of seizures
The attending physician decided on the prescription of
prophylactic or treatment doses of antiepileptic drugs.
Rectal diazepam (0.5 mg/kg) or paraldehyde (0.2 ml/kg)
was given to stop seizures (CS or ES) lasting longer than
5 min. Some children were prescribed prophylactic paren-
teral phenytoin (18 mg/kg) or phenobarbital (15–20 mg/kg)
before cEEG commenced. Others received these anticon-
vulsants only when there was more than one CS or ES. If
the episode continued, then repeat doses were given after
6–12 h.
Severity of illness and outcome assessment
The Paediatric Index of Mortality (PIM) [18] and ACS on
admission were recorded. There was active surveillance
for death during the study. Treatment was only withdrawn
in the event of brain death. All children who survived
initial hospitalization were followed-up at 1 month after
admission to hospital by one of the paediatric neurologists
in the study, who undertook a detailed history from the
parents about any change from premorbid cognition and
behaviour, as well as a detailed neurological examination.
Using this information, outcome was classified on the
Glasgow Outcome Scale by an investigator (B.G.R.N.)
blinded to the admission clinical and cEEG data. Out-
come was dichotomized: children who remained in a
vegetative state, or had a movement disorder precluding
ambulation, or severe learning difficulties, were classified
as having an unfavourable outcome, with the remainder as
having a favourable outcome. Where possible, and always
if the neurological examination was abnormal, defined as
reduced level of consciousness, or if abnormalities of
motor, visual, auditory or cognitive function were found,
further follow-up was arranged and longer term outcome
assessed using the same methodology.
Data and statistical analyses
Analysis of ES episodes
An ES was defined as the presence of rhythmical spike-
and-wave activity for more than 15 s, and was considered
subclinical if there were no clinical manifestations. For
the CFAM data, all traces were analysed independently
for the presence of ES by S.G.B. and F.J.K.; consensus
Fig. 1 Oxford Medilog trace from a girl aged 4 years with
cavernous sinus thrombosis and a cardiac arrest showing a very
prolonged ES, which commenced at 0130 hours (a). The discharges
continued unrecognized by the nursing staff until 0500 hours (b).
Subsequently the EEG became isoelectric and the child died a brain
death
Fig. 2 CFAM trace from a baby aged 3 months with Reye’s
syndrome showing a sudden increase in amplitude of compressed
trace at A and B associated with a rhythmical seizure discharge on
the raw EEG playout at C. The main graticules, when the trace is
being written, are at intervals of 0.5 cm
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was reached if there was any disagreement. The number
and total duration of ES activity, and duration of the
longest ES, were obtained from the traces.
Statistical analyses
Differences in demographics and outcome measures
between the three groups (UK neonates, UK infants and
children, Kenyan infants and children) were tested using
one-way parametric or Kruskal-Wallis ANOVA or the chi-
squared test as appropriate. The hypothesis test for pro-
portions was used to compare prevalences. Logistic
regression models were used to investigate potential pre-
dictors of two outcomes: death in the first month and
unfavourable outcome at 1 month amongst the survivors,
including clinically important potential predictors: cohort
(UK or Kenya), aetiology, PIM score, ACS and EEG grade
on admission, prophylactic anticonvulsant administration
with benzodiazepines and/or phenobarbitone, CS at any
time, and the presence (yes/no), number, total duration and
single longest duration of ES. For prediction of unfa-
vourable outcome, the duration of EEG monitoring was
also explored as a potential confounder. Unadjusted and
adjusted odds ratios (OR) with 95 % confidence intervals
(CI) are presented in the tables. Cerebral malaria was
chosen as the reference because seizures and coma are
common, while outcome is variable, although the malaria
parasite does not directly invade the brain parenchyma.
Variables were added to multivariable models according
to statistical significance in a forward step-wise fashion.
All variables retained led to a significant change in log
likelihood. Variables not initially significant were inves-
tigated after adjustment for other factors. The significance
level for inclusion was primarily set at p \ 0.05.
Results
Aetiology of coma
Aetiological categories included: cerebral malaria
(defined as Plasmodium falciparum asexual parasitaemia
in a normoglycaemic patient unable to localize a painful
stimulus at least 6 h after last seizure [19]), meningitis
(bacteria identified in the cerebrospinal fluid by micros-
copy, culture or antigen), encephalitis (febrile illness
with previous viral infection or pleocytosis and no bac-
teria), Reye-like syndrome (coma with high blood
ammonia), hypoxic–ischaemic encephalopathy (wit-
nessed cardiopulmonary arrest), head injury (evidence of
trauma to the head), hypertensive encephalopathy (coma
with severe hypertension), thrombotic thrombocytopoenic
purpura/haemolytic uraemic syndrome (coma associated
with fragmented or burr red cells and thrombocyto-
paenia), systemic vasculitis (coma associated with
laboratory findings diagnostic of autoimmunity), intrace-
rebral haemorrhage (spontaneous coma with intracerebral
bleeding on CT), drug toxicity and cavernous sinus
thrombosis (Table 1) .
The prevalence of ES activity during coma
Overall, ES were detected in 74 (36 %; 95 % CI 30, 43 %)
of the 204 comatose children with cEEG. The number of
seizures and total duration of seizures correlated with total
duration of monitoring (R2 = 0.09, p = 0.0005; R2 = 0.05;
p=0.001, respectively). ES occurred in 69 (62.7 %) of 110
patients with CS compared with 5 (5.3 %) of 94 with no CS
witnessed (difference 5.7 %, 95 % CI 4.6, 66.4 %;
p = 0.0005). There was no difference between the 158
ventilated patients receiving NMB agents (36 %, 95 % CI
29, 44 %) and the 46 non-ventilated children (37 %, 95 %
CI 26, 51 %; p = 0.5), between the neonates (44 %, 95 %
CI 25, 66 %) and the older children (36 %, 95 % CI 29,
43 %; p = 0.5) or between the seizures detected with the
CFAM (38 %, 95 % CI 31, 46 %) and with the Oxford
Medilog (31 %, 95 % CI 20, 44%; p = 0.2).
In 46 Kenyan children who were not mechanically
ventilated, cEEG was undertaken for a median of 12
(range 2–90) h (Table 1). CS were seen in 42 (91 %) and
at least one ES was seen in 17 (40 %, 95 % CI 26, 57 %).
ES were only present in those patients who had CS. The
types of CS noted were generalized tonic–clonic seizures
(n = 7), and only subtle seizures (e.g. clonic jerking of
the fingers or epileptic nystagmus) in the other 35
patients. The median number of ES per patient was 7
(range 1–46). In 15 of the 46 children (33 %, 95 % CI 20,
48 %), these episodes occurred without any clinical
concomitants (i.e. NCS). Of the 17 children with ES, 15
(88 %, 95 % CI 64, 99 %) also exhibited CS at some
time. NCS were not observed as the sole form of seizure
activity in any individual.
In 140 unconscious mechanically ventilated infants
and children with a variety of diagnoses (Table 1), cEEG
monitoring was carried out for a median of 48 h (range
4–630 h) commencing, on average, within 3 h of admis-
sion to the PICU. Before admission and the use of NMB
agents, 57 of the 140 patients (41 %, 95 % CI 33, 49 %)
had CS. In 11, ES activity was associated with subtle
clinical events, e.g. clonic finger jerking. In contrast to the
spontaneously breathing subgroup, ES were found in 5 of
83 patients (6 %, 95 % CI 2, 14 %) in whom CS had not
been observed before or during admission.
Before prescription of NMB agents, 11 of 18 neonates
with cardiac disease (61 %, 95 % CI 39, 80 %) had CS, 8
of whom (73 %, 95 % CI 43, 90 %) also had ES
(Table 1), while ES were not detected in any others.
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Outcome and significance of ES activity during coma
Of the 204 patients, 93 (46 %, 95 % CI 39, 52 %) had
died by 1 month. Mortality was higher in the infants and
children requiring mechanical ventilation for life support
(Table 2). In univariable logistic regression, in addition to
absence of CS at any time, death was associated with the
following findings on admission: aetiology, higher PIM
score, lower ACS and lower cEEG grade (Table 2). These
five variables were entered into the multivariable model.
Table 1 Characteristics of UK and Kenyan populations comprising in total 204 comatose neonates, infants and children
UK neonates
(n = 18)
UK infants and
children (n = 140)
Kenyan infants and
children (n = 46)
Boys 11 (61 %) 71 (51 %) 24 (52 %)
Age (years)
Median 0.01 2.0 2.7
Range 0–0.08 0.1–15 0.25–7
Aetiology
Cerebral malaria 0 0 42
Meningitis 0 6 3
Encephalitis 0 10 1
Reye-like syndrome 0 3 0
Hypoxic–ischaemic 18 96 0
Head injury 0 18 0
Hypertensive encephalopathy 0 1 0
Intracerebral haemorrhage 0 1 0
Cavernous sinus thrombosis 0 1 0
Drug toxicity (toluene) 0 1 0
Systemic vasculitis 0 1 0
Thrombotic thrombocytopenic
purpura/haemolytic uraemic syndrome
0 2 0
Paediatric index of mortality
Median 13.1 56 12.8
Range 2.8–91.3 23.6–97.9 7.5–30.4
Initial summated ACS
Median 3 4 7
Range 3–12 3–12 3–12
Clinical seizures witnessed prior to monitoring 11 (61 %) 57 (41 %) 42 (91 %)
Type of EEG recording
Oxford Medilog 7 45 0
CFAM 11 95 46
Duration of EEG monitoring (h)
Median 60 48 12
Range 6–120 4–630 2–90
EEG grade on admission
Normal 3 30 6
Excess slow with [3 % fast 7 37 26
Excess slow with \3 % fast 1 20 11
Low amplitude (10th \9 lV) 4 30 3
Burst suppression 2 15 0
Isoelectric 1 8 0
Electroencephalographic seizures (ES) (%) 8 (44 %) 49 (35 %) 17 (37 %)
Number of ES seizures
Median 7 28 7
Range 3–137 1–531 1–46
Total duration of ES (min)
Median 44 135 63
Range 10–517 2–2,358 6–290
Duration of longest ES (min)
Median 9 18 16
Range 4–24 2–1,440 1–232
Survived to 1 month
No. of patients 11 60 40
Percent of total 61 (95 % CI 39, 80) 43 (95 % CI 35, 51) 87 (74, 94)
Unfavourable neurological outcome at 1 month
No. of patients 1 23 5
Percent of survivors at 1 month 9 (95 % CI 16, 38) 38 (95 % CI 27, 51) 13 (95 % CI 6, 26)
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Table 2 Logistic regression for prediction of death in the first month
Variable Survivors
(n = 111)
Deaths
(n = 93)
Odds ratios
Unadjusted 95 % CI Adjusted 95 % CI
Age (years)
Median 2 1.5 0.99 0.92–1.07
Range 0–14 0–15
Age group
Neonate 11 7 0.74 0.28–2.0
Older child 100 86
Sex
Male 61 45 1.3 0.75–2.26
Female 50 48
Cohort
UK 71 87 8.17 3.28–20.4
Kenya 40 6
Aetiology
Cerebral malaria 38 4 1.0 –
Hypoxic–ischaemic 45 69 14.6 4.9–43.6
Head injury 10 8 7.6 1.9–30.4
Encephalitis 10 1 0.97 0.10–9.50
Meningitis 4 5 11.9 2.24–63.1
Reye’s syndrome 2 1 4.75 0.35–64.7
Other 2 5 23.8 3.43–164.7
On admission
PIM score
Median 30.4 56.5 1.032 1.020, 1.044
Range 3.7, 97.9 2.8, 95.7
ACS
Median 6 3 0.71 0.62–0.82
Range 3–12 3–12
cEEG
Normal 31 8 1.0 –
Excess slow with [3 % fast 43 27 2.43a 0.98–6.1a
Excess slow with \3 % fast 14 18 5.0a 1.75–14.2a
Low amplitude (10th \9 lV) 19 18 3.67a 1.33–10.1a
Burst suppression 4 13 12.6a 3.22–49.3a
Isoelectric 0 9 – –
During admission
Presence of ES
Yes 45 29 0.67 0.37–1.19
No 66 64
Number of ES
Median 0 0 0.993 0.984–1.001
Range 0–531 0–109
Duration of ES (min)
Median 0 0 1.000 0.999–1.001
Range 0–2,358 0–1,655
Duration of longest seizure (min)
Median 0 0 1.001 0.999–1.003
Range 0–360 0–1,440
At any time
Clinical seizures
Yes 74 36 0.32 0.18–0.56
No 37 57
Benzodiazepine before monitoring
Yes 18 13 0.84 0.39–1.72
No 93 80
Phenytoin or phenobarbital before monitoring
Yes 11 9 1.03 0.41–2.60
No 100 84
PIM score 1.027 1.012, 1.042
ACS 0.813 0.700, 0.943
cEEG
Normal 1.0 –
Excess slow with [3 % fast 5.43a 1.90, 15.6a
Excess slow with \3 % fast 8.71a 2.58, 29.4a
Low amplitude (10th \9 lV) 3.78a 1.23, 11.7a
Burst suppression 10.68b 2.31, 49.4a
Isoelectric – –
Absence of CS at any time 2.38 1.18, 4.81
a Compared to normal EEG on admission
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PIM score, ACS and EEG grade on admission as well as
absence of CS at any time were associated with death
(Table 2) in multivariable logistic regression after
adjustment for aetiology. Anticonvulsant prophylaxis was
not associated with mortality.
At 1 month, 29 patients (26 %, 95 % CI 19, 35 %, of
the survivors; 14 %, 95 % CI 10, 20 %, of the total) were
either severely handicapped or in a vegetative state. Out-
come in survivors was worse (Table 3) in the ventilated
cohort, in those with longer duration of monitoring, and in
those with hypoxic–ischaemic aetiology, lower PIM score,
lower cEEG grade, CS at any time, ES at any time, and
larger number and longer duration of ES activity (Fig. 3)
and longest duration ES. No child had a favourable out-
come when there had been more than 139 seizures, or a
total duration of ES of more than 759 min, or an individual
ES of more than 360 min. There was no significant asso-
ciation with age, sex or the use of anticonvulsant
prophylaxis. In the final model, the presence of ES and
PIM score remained in the model for predicting unfa-
vourable neurological outcome (Table 3) independent of
cohort and duration of EEG monitoring. None of the other
variables was statistically significant after taking these
variables into account. Longer term outcome was available
for all 71 UK survivors at a median of 6 months (range
1.5–144 months) and for 13 of 40 Kenyan survivors,
including all five with an unfavourable outcome at
1 month, at a median of 12 months (range 1.5–40 months).
Of the 29 with an unfavourable outcome at 1 month, on
final follow-up at a median of 6 months (range
1.5–144 months), one had improved to moderate handicap,
eight had died and the remainder stayed in the same out-
come category. Although four of those with a favourable
outcome at 1 month subsequently died, none deteriorated
neurologically when assessed at a median age of 6 months
(range 1.5–48 months).
In a multivariable model for prediction of death which
included ES, the odds ratio and confidence intervals
changed only marginally. Adding the predictors of death
to a multivariable model for prediction of outcome in
survivors did not change the model and minimally altered
the odds ratio and confidence intervals for the effect of
ES.
Discussion
In this study ES occurred in over one-third of comatose
children, and the prevalence of ES was related to the
presence of CS and the underlying aetiology. Our data on
prevalence of ES is consistent with those of previous
studies of CS in unconscious adults and children [20–32]
and of ES in paediatric [10, 33, 34] and adult intensive
care [35], but not that of a recent study which detected ES
in only 7 % of patients [36]. Independently of aetiology,
PIM, ACS and the presence of CS, normal background
cEEG activity predicted survival, while the presence of
ES activity predicted an unfavourable outcome in survi-
vors, although, as in an adult study [37], good outcomes
may be seen after very prolonged seizures.
Most of the children had CS before EEG monitoring,
but five (2 %), all ventilated, had only ES, i.e. NCS. This
is a similar proportion to those found in children and
adults who were in nonconvulsive status epilepticus on
EEG during the first 3 days after presentation in coma [9,
38]. Among the nonventilated children, all who had ES
had CS. It would seem prudent to monitor EEG to detect
NCS in children who remain unconscious or in children
with an acute encephalopathy and CS requiring NMB
agents for ventilation [9], or in the absence of a reliable
history, e.g. after non-accidental injury.
These results must be interpreted cautiously. The cri-
teria for admission to the high-dependency unit and PICU
differed, although our cohort had a variety of diagnoses,
so we could assess whether the effect of seizures was
independent of aetiology. Since we monitored only one to
three channels in these cohorts, a proportion of seizures
may have been missed [5]. Patients with traumatic brain
injury or intracranial haemorrhage secondary to arterio-
venous malformation may have unilateral discharges,
while those with status epilepticus in the context of
polymerase-c mutations [39] or posterior reversible
encephalopathy syndrome [40] typically have occipital
involvement. These conditions should be borne in mind
when the choice of electrode placement for longer term
single or dual channel EEG monitoring is decided. The
use of cEEG should be evaluated by a comparison
between standard EEG and cEEG at the first opportunity.
Although detection of any seizure in a patient may not be
better, two or more channels may detect more seizures,
particularly in unilateral disease [41]. Further studies
comparing one- and two-channel amplitude integrated
displays with raw EEG are warranted but as seizure
detection is the priority, there may be an advantage in
setting up a simple single-channel amplitude integrated
EEG monitor with raw EEG display on admission, as ES
are detected in the first hour in the majority of patients
with seizures [33]. In our data, there was no evidence that
monitoring three channels with the Oxford Medilog had
any advantage over monitoring one or two channels with
the CFAM which displays raw EEG regularly and on
demand in addition to the advantage of easier review in
real time allowed by the amplitude integrated display
[10]. The effect on outcome of ES not manifest as
rhythmical spike-and-wave detectable with limited chan-
nel EEG monitoring should be the subject of prospective
studies with multichannel cEEG. We found an association
between CS with survival, at face value surprising but
previously documented after head injury [42], perhaps
because CS precipitate admission. ES did not predict
death either, perhaps because death is related to acute
859
Table 3 Odds ratios from logistic regression for prediction of unfavourable outcome in 111 survivors at 1 month
Variable Good outcome
(n = 82)
Unfavourable
outcome (n = 29)
Odds ratios for unfavourable outcome
Unadjusted 95 % CI Adjusted 95 % CI
Age – – 0.93 0.81–1.07
Age group
Neonate 10 1 0.26 0.03–2.1
Older child 72 28
Gender
Male 47 14 1.44 0.62–3.37
Female 35 15
Cohort
UK 47 24 3.57 1.24–10.3
Kenya 35 5
Duration of monitoring (h)
Median 47 120 1.010 1.004, 1.016
Range 2–276 9–264
Aetiology
Cerebral malaria 35 3 1.0 –
Hypoxic–ischaemic 28 17 7.08 1.89–26.6
Head injury 9 1 1.30 0.12–14
Encephalitis 8 2 2.92 0.42–20.4
Meningitis 0 4 – –
Reye-like syndrome 0 2 – –
Other 2 0 – –
On admission
PIM score
Median 26 52.1 1.034 1.015–1.053
Range 3.7–97.3 7.5–97.9
ACS
Median 6 5 1.17 0.97–1.41
Range 3–12 3–12
cEEG
Normal 26 5 1.0 –
Excess slow with [3 % fast 34 9 3.33a 0.29–38.1a
Excess slow with \3 % fast 11 3 11.0a 0.82–147.9a
Low amplitude (10th \9 lV) 10 9 11.3a 1.05–122a
Burst suppression 1 3 15.6a 1.33–182a
Isoelectric 0 0 – –
During admission
Presence of ES
Yes 21 24 13.9 4.72–41.2
No 61 5
Number of ES
Median 0 13 1.027 1.007–1.035
Range 0–137 0–531
Duration of ES (min)
Median 0 78 1.004 1.001–1.006
Range 0–759 0–2,358
Duration of longest ES (min)
Median 0 11 1.007 1.001–1.014
Range 0–360 0–360
At any time
Clinical seizures
Yes 49 25 4.21 1.34–13.2
No 33 4
Benzodiazepine before monitoring
Yes 16 2 0.31 0.07–1.42
No 66 27
Phenytoin or phenobarbital before monitoring
Yes 8 3 1.07 0.26–4.33
No 74 26
Presence of EEG seizures 15.4 4.7, 49.7
PIM score 1.036 1.013, 1.059
a Compared to normal EEG on admission
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intracranial hypertension independent of seizures. We
were only able to determine outcome in all the children at
1 month, and the number of surviving patients was rela-
tively small for multivariable logistic regression. Despite
these limitations, our data demonstrate an association
between ES and unfavourable neurological outcome in
survivors independent of age, aetiology and cohort. Fur-
ther prospective studies with long-term follow-up are
required, however, before definitive recommendations on
monitoring and treatment can be made.
Routine [3] or cEEG [9] with video recording detects
NCS or nonconvulsive status epilepticus in at least one-
third of PICU patients presenting with CSE. There is
concern that ongoing ES activity is under-recognised in
these patients, who are usually sedated and sometimes
given NMB agents for ventilation [3, 9]. In children in
coma, Jette et al. [9] suggested excluding NCS even if
there are no CS, and our data provide further evidence for
this recommendation. However, multichannel cEEG is
labour-intensive and expensive, treatment protocols have
not been defined, and there are few data on any associa-
tion with neurological outcome in coma with acute
symptomatic CSE. Further research looking at the reli-
ability of one- or two-channel cEEG monitoring devices
in diagnosing NCS is required as the technical issues are
resolved and our data add to the evidence that outcome
may be predicted on the PICU [10].
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